Bumetanide in Patients With Alzheimer's Disease

NCT06052163 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Bumetanide
DRUG: Placebo

Sponsor

Stanford University